Literature DB >> 21954252

Evidence used to support the achievement and maintenance of elimination of rubella and congenital rubella syndrome in the United States.

Susan E Reef1, Susan B Redd, Emily Abernathy, Preeta Kutty, Joseph P Icenogle.   

Abstract

On 29 October 2004, an expert panel was convened to review the status of elimination of rubella and congenital rubella syndrome (CRS) in the United States. Primarily based on 5 types of information presented--epidemiology of reported cases, molecular epidemiology, seroprevalence, vaccine coverage, and adequacy of surveillance--the panel unanimously agreed that rubella virus is no longer endemic in the United States. Since 2004, new data continue to support the conclusion that elimination has been achieved and maintained. In documenting elimination in the United States, each of the 5 types of data provided evidence for elimination and collectively provided much stronger evidence than any one type could individually. As countries document the elimination of rubella and CRS, many sources and types of data will likely be necessary. Rigorous data evaluation must be conducted to look for inconsistencies among the available data. To maintain elimination, countries should maintain high vaccine coverage, adequate surveillance, and rapid response to outbreaks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21954252     DOI: 10.1093/infdis/jir420

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Results of the rubella elimination program in Catalonia (Spain), 2002-2011.

Authors:  Irene Barrabeig; Nuria Torner; Ana Martínez; Gloria Carmona; Pilar Ciruela; Joan Batalla; Josep Costa; Sergi Hernández; Luis Salleras; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-08       Impact factor: 3.452

Review 2.  Post-exposure passive immunisation for preventing rubella and congenital rubella syndrome.

Authors:  Megan K Young; Allan W Cripps; Graeme R Nimmo; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2015-09-09

3.  Evolutionary analysis of rubella viruses in mainland China during 2010-2012: endemic circulation of genotype 1E and introductions of genotype 2B.

Authors:  Zhen Zhu; Pierre Rivailler; Emily Abernathy; Aili Cui; Yan Zhang; Naiyin Mao; Songtao Xu; Shujie Zhou; Yue Lei; Yan Wang; Huanying Zheng; Jilan He; Ying Chen; Chongshan Li; Fang Bo; Chunfang Zhao; Meng Chen; Peishan Lu; Fangcai Li; Suyi Gu; Hui Gao; Yu Guo; Hui Chen; Daxing Feng; Shuang Wang; Xiaomin Tang; Yake Lei; Yan Feng; Lili Deng; Tian Gong; Lixia Fan; Wenbo Xu; Joseph Icenogle
Journal:  Sci Rep       Date:  2015-01-23       Impact factor: 4.379

4.  Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda.

Authors:  Fred Bagenda; Edgar Mugema Mulogo; Richard Onyuthi Apecu; Anette Kisakye; Benard Toliva Opar
Journal:  BMC Infect Dis       Date:  2020-03-12       Impact factor: 3.090

5.  Illuminating uveitis: metagenomic deep sequencing identifies common and rare pathogens.

Authors:  Thuy Doan; Michael R Wilson; Emily D Crawford; Eric D Chow; Lillian M Khan; Kristeene A Knopp; Brian D O'Donovan; Dongxiang Xia; Jill K Hacker; Jay M Stewart; John A Gonzales; Nisha R Acharya; Joseph L DeRisi
Journal:  Genome Med       Date:  2016-08-25       Impact factor: 11.117

6.  Epidemiological and molecular investigation of a rubella outbreak, Romania, 2011 to 2012.

Authors:  Mihaela Lazar; Emily Abernathy; Min-Hsin Chen; Joseph Icenogle; Denisa Janta; Aurora Stanescu; Adriana Pistol; Sabine Santibanez; Annette Mankertz; Judith M Hübschen; Grigore Mihaescu; Gheorghe Necula; Emilia Lupulescu
Journal:  Euro Surveill       Date:  2016-09-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.